Collecting Blood and Tissue Samples From Family Members of Patients With Pancreatic Diseases, Pancreatic Cancer, and Melanoma

Familial Pancreatic Cancer Clinical Trial

Official title:

Biospecimen Resource for Familial Pancreas Research, a Data and Tissue Registry (Also Known as a Bio-repository, Bio-bank, Data and Tissue Database, Data and Tissue Bank, Etc.) to Help Advance Research in Familial Pancreas Disease

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT00835133
• Other study ID #: 355-06
• Secondary ID: R01CA097075-08CD
• Status: Recruiting
• Start date: August 2002
• Est. completion date: September 2024

Study information

• Verified date: July 2023
• Source: Mayo Clinic
• Contact: Adriana M Delgado, CCRP
• Phone: 1-800-914-7962
• Email: pancreas[@]mayo.edu
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

RATIONALE: Collecting and storing samples of blood and tissue from family members of patients with cancer to test in the laboratory may help the study of cancer in the future. PURPOSE: This clinical trial is collecting blood and tissue samples from family members of patients with pancreatic disease, pancreatic cancer, and melanoma.

Description:

OBJECTIVES: - To collect clinical history, family history, and blood and/or tissue samples from family members of patients diagnosed with pancreatic diseases, pancreatic cancer, or melanoma. - To learn whether inherited factors increase the risk of pancreatic diseases, pancreatic cancer, or other cancers. OUTLINE: Study participants undergo collection of blood and/or tissue samples as well as survey data for inclusion in a familial data and tissue registry. Participants complete two baseline surveys regarding their personal, family, health, and environmental exposure histories and regarding their opinions on cancer and cancer screening. Patients also complete a follow-up survey at 1 year and undergo review of their medical records.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 12000
• Est. completion date: September 2024
• Est. primary completion date: September 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 120 Years

Eligibility

DISEASE CHARACTERISTICS:

• Meets 1 of the following criteria:
• Has at least 2 blood relatives with pancreatic cancer (both must be related)
• Has at least 1 blood relative with pancreatic cancer and 1 with melanoma (both must be related)

PATIENT CHARACTERISTICS:

• Mentally competent and able to provide informed consent
• Able to understand and read English

PRIOR CONCURRENT THERAPY:

• Not specified

Related Conditions & MeSH terms

• Familial Pancreatic Cancer
• Pancreatic Neoplasms

Intervention

Other:
• biologic sample preservation procedure
one blood sample
• medical chart review
confirmation of cancer diagnosis
• survey administration
at baseline enrollment and 12 months post-enrollment

Locations

Country	Name	City	State
United States	Mayo Clinic Cancer Center	Rochester	Minnesota

Sponsors (2)

Lead Sponsor	Collaborator
Mayo Clinic	National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Collection of familial data and biospecimens in a data and tissue repository for familial pancreas research		baseline

External Links

•   Mayo Clinic Clinical Trials